The current longitudinal study takes an important step towards reducing long-term complications due to severe malaria by analysing multimodal associations between brain injury biomarkers (UCH-L1, NF-L, and GFAP) detectable in systemic circulation, and clinical outcomes, such as mortality and cognitive impairment. This evidence concerns the gene GFAP and malaria.